Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran
-
Saeed Shoja
,
Mojtaba Moosavian
,
Amir Peymani
,
Mohammad-Amin Tabatabaiefar
,
Soodabeh Rostami
,
Nasim Ebrahimi
Abstract
Background and Objectives: Carbapenem resistant A. baumannii is an emerging cause of nosocomial infections. The aims of this study were identification of the most prevalent of carbapenem resistant genes, molecular typing and antimicrobial evaluation of A.baumannii in intensive care units.
Materials and Methods: Two hundred and six A. baumannii were isolated from tracheal tube discharge of hospitalized patients at different intensive care units in Ahvaz, Iran. Antimicrobial susceptibility test was done on all isolates. Multiplex and singleplex PCR were performed for detection of bla OXA-23-like, bla OXA-24-like, bla OXA-51-like, bla OXA-58-like, bla VIM, bla IMP, bla SPM and bla NDM genes. Genetic relationship of all isolates was determined by REP-PCR method.
Results: Out of 206 examined isolates, 198 (96.1%) isolates were resistant to imipenem and meropenem. However 3.9% isolates were sensitive to these antibiotics. The bla OXA-23-like and bla OXA-24-like genes were detected in 85% and 8.7% of strains, respectively. No bla OXA-58- like, bla IMP, bla VIM, bla SPM and bla NDM were detected. REP-PCR results showed that isolates were belonged to five genotypes: Genotype A was the most prevalent (P- value < 0.001): it was observed in 75 of 206 strains (36.4%). Genotype B, and C were found in 28.6% and 27.7%, respectively. The rate of other genotypes was as follows: D (2.4%), E (1%).
Conclusion: Based on the obtained results, the rate of carbapenem resistance was high among of A. baumannii which was isolated from intensive care units patients and oxacillinase genes were the most prevalent carbapenem resistant genes. These results revealed that three clones, A, B and C of A.baumannii are common in our hospitals.
Kempf M, Rolain JM. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents 2012; 39:105-114.
Peymani A, Higgins PG, Nahaei MR, Farajnia S, Seifert H. Characterisation and clonal dissemination of OXA- 23-producing Acinetobacter baumannii in Tabriz, northwest Iran. Int J Antimicrob Agents 2012; 39:526-528.
Garnacho-Montero J, Ortiz-Leyba C, Fernandez- Hinojosa E, Aldabo-Pallas T, Cayuela A, Marquez- Vacaro JA, et al. Acinetobacter baumannii ventilator- associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005; 31: 649-655.
Joseph NM, Sistla S, Dutta TK, Badhe AS, Parija SC.Ventilator-associated pneumonia: role of colonizers and value of routine endotracheal aspirate cultures. Int J Infect Dis 2010; 14: 723-729.
Shete VB, Ghadage DP, Muley VA, Bhore AV. Multi- drug resistant Acinetobacter ventilator-associated pneumonia. Lung India 2010; 27 : 217-220.
Manageiro V, Jones-Dias D, Ferreira E, Louro D, Canica M. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118. Int J Antimicrob Agents 2012; 40: 398-403.
Lee HY, Chen CL, Wang SB, Su LH, Chen SH, Liu SY, et al. Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int J Antimicrob Agents 2011; 37: 302-308.
Yan ZQ, Shen DX, Cao JR, Chen R, Wei X, Liu LP, et al. Susceptibility patterns and molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains from three military hospitals in China. Int J Antimicrob Agents 2010; 35: 269-73.
Dizbay M, Altuncekic A, Sezer BE, Ozdemir K, Arman D. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. Int J Antimicrob Agents 2008; 32: 29-32.10. Irfan S, Turton JF, Mehraj J, Siddiqui SZ, Haider S, Zafar A, et al. Molecular and epidemiological characterisation of clinical isolates of carbapenem- resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan. J Hosp Infect 2011; 78: 143-148.11. Winn W, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P Woods G(2006). Koneman‘s Color Atlas and Textbook of Diagnostic microbiology 6 ed. Lippincott Williams & Wilkins, Philadelphia.
Clinical and Laboratory Standards Institute, 2011.Performance standards for antimicrobial susceptibility testing: 21th informational supplement. CLSI document M100-S21. CLSI, Wayne, Pa.
Wyeth Pharmaceuticals. Tygacil (tigecycline) for injection [Package insert]. 2005. Wyeth Pharmaceuticals Inc., Philadelphia, PA.
Bou G, Cervero G, Dominguez MA, Quereda C, Martinez-Beltran J. PCR-based DNA fingerprinting (REP-PCR,AP-PCR)andpulsed-fieldgelelectrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect 2000; 6: 635-643.
Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351-3.
Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011; 70: 119-123.
Zong Z, Lu X, Valenzuela JK, Partridge SR, Iredell J.An outbreak of carbapenem-resistant cinetobacter baumannii producing OXA-23 carbapenemase in western China. Int J Antimicrob Agents 2008; 31: 50-4.
Martin-Lozano D, Cisneros JM, Becerril B, Cuberos L, Prados T, Ortiz-Leyba C,et al. Comparison of a repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia. J Clin Microbiol 2002; 40:4571-4575.
Snelling AM, Gerner-Smidt P, Hawkey PM, Heritage J, Parnell P, Porter C, et al. Validation of use of whole- cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for typing strains belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex and application of the method to the investigation of a hospital outbreak. J Clin Microbiol 1996; 34: 1193-1202.
Nomanpour B, Ghodousi A, Babaei A, Abtahi H, Tabrizi M, Feizabadi M. Rapid, cost-effective, sensitive and quantitative detection of Acinetobacter baumanniifrom pneumonia patients. IranJ microbiol 2011; 3: 162-9.
D’Arezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P. Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother 2011; 66: 54-61.
Feizabadi MM, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M, et al. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn J Infect Dis 2008; 61:274-278.
Touati M, Diene SM, Racherache A, Dekhil M, Djahoudi A, Rolain JM. Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int J Antimicrob Agents 2012; 40: 89-91.
Carvalho KR, Carvalho-Assef AP, Peirano G, Santos LC, Pereira MJ, Asensi MD. Dissemination of multidrug- resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int. Int J Antimicrob Agents 2009; 34: 25-8.
Ergin A, Hascelik G, Eser OK. Molecular characterization of oxacillinases and genotyping of invasive Acinetobacter baumannii isolates using repetitive extragenic palindromic sequence-based polymerase chain reaction in Ankara between 2004 and 2010. Scand J Infect Dis 2013; 45: 26-31.
Ben RJ, Yang MC, Hsueh JC, Shiang JC, Chien ST.Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan. Int J Antimicrob Agents 2011; 38: 403-408.
Kulah C, Mooij MJ, Comert F, Aktas E, Celebi G, Ozlu N,et al. Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey. Int J Antimicrob Agents 2010; 36:114-118.
Hrabak J, Stolbova M, Studentova V, Fridrichova M, Chudackova E, Zemlickova H. NDM-1 producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt, July 2011.Euro Surveill 2012; 17: 1-3.
Peymani A, Nahaei MR, Farajnia S, Hasani A, Mirsalehian A, Sohrabi N, et al. High prevalence of metallo-beta-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn J Infect Dis 2011; 64: 69-71.
Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother 2010; 65: 2253-2254.
Mohamed NM, Raafat D. Phenotypic and Genotypic Detection of Metallo-beta-lactainases in Imipenem- resistant Acinetobacter baumannii Isolated from a Tertiary Hospital in Alexandria, Egypt. Res J Microbiol 2011; 6: 750-760.
Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran Hospitals. Iran J Microbiol 2011; 3: 68-74.
Netsvyetayeva I, Sikora M, Golas M, Swoboda-Kopec E, de Walthoffen SW, Dembicka O, et al. Acinetobacter baumannii multidrug-resistant strain occurrence in liver recipients with reference to other high-risk groups.Transplant Proc 2011; 43: 3116-3120.
Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Countries 2009; 3:335-341.
Huang L, Sun L, Xu G, Xia T (2008). Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital. Diagn Microbiol Infect Dis 2008; 62: 326-332.
| Files | ||
| Issue | Vol 5 No 4 (2013) | |
| Section | Articles | |
| Keywords | ||
| Acinetobacter baumannii Carbapenem resistant Intensive Care Units | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
